Results

eNauka >  Rezultati >  Fenebrutinib Compared to Placebo and Adalimumab in Patients with Inadequate Response to Either Methotrexate Therapy Or Prior Tnf Therapy: Phase 2 Study
Naziv: Fenebrutinib Compared to Placebo and Adalimumab in Patients with Inadequate Response to Either Methotrexate Therapy Or Prior Tnf Therapy: Phase 2 Study
Autori: Cohen, Stanley B; Tuckwell, Katie; Katsumoto, Tamiko R; Zhao, Rui; Lee, Chin; Berman, Alberto; Damjanov, Nemanja S; Fedkov, Dmytro; Jeka, Slawomir; Genovese, Mark C
Godina: 2019
Publikacija: ANNALS OF THE RHEUMATIC DISEASES
ISSN: 0003-4967 Annals of the Rheumatic Diseases Pretraži identifikator
Tip rezultata: Konferencijski rad
Kolacija: vol. 78 str. 80-81
DOI: 10.1136/annrheumdis-2019-eular.4469
WoS-ID: 000472207100239
URI: https://enauka.gov.rs/handle/123456789/814197
Izvor metapodataka: (Preuzeto iz Nasi u WoS)
M-kategorija: 
Mp kategorija će biti prikazana naknadno.

3
OpenCitations
3
WEB OF SCIENCETM
Altmetric
Dimensions
Unpaywall

Google ScholarTM

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.